Drugs / G-CSF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05382390 Background | Jan 2022 → Jan 2024 | acute myeloid leukemia | Huihan Wang | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | “granulocyte colonystimulating factor (G-CSF)” NCT05382390 ↗ |
| Modality | Protein / enzyme biologic | “two hematologic growth factors, recombinant human thrombopoietin (rhTPO) and granulocyte colonystimulating factor (G-CSF)” NCT05382390 ↗ |